Invention Grant
- Patent Title: Thienopyrimidine as CDC7 kinase inhibitors
- Patent Title (中): 噻吩并嘧啶作为CDC7激酶抑制剂
-
Application No.: US13254551Application Date: 2010-03-04
-
Publication No.: US08691828B2Publication Date: 2014-04-08
- Inventor: Yuya Oguro , Osamu Kurasawa
- Applicant: Yuya Oguro , Osamu Kurasawa
- Applicant Address: JP Osaka-shi
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka-shi
- Agency: Hogan Lovells US LLP
- International Application: PCT/JP2010/054073 WO 20100304
- International Announcement: WO2010/101302 WO 20100910
- Main IPC: C07D495/04
- IPC: C07D495/04 ; A61K31/519 ; A61P35/00
Abstract:
The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof, or a prodrug thereof, which is useful for the prophylaxis or treatment of cancer.
Public/Granted literature
- US20120040981A1 THIENOPYRIMIDINE AS CDC7 KINASE INHIBITORS Public/Granted day:2012-02-16
Information query
